201 related articles for article (PubMed ID: 28884432)
1. Plasma enterolactone and risk of prostate cancer in middle-aged Swedish men.
Wallström P; Drake I; Sonestedt E; Gullberg B; Bjartell A; Olsson H; Adlercreutz H; Tikkanen MJ; Wirfält E
Eur J Nutr; 2018 Oct; 57(7):2595-2606. PubMed ID: 28884432
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of plasma enterolactone and prostate cancer risk (Sweden).
Stattin P; Bylund A; Biessy C; Kaaks R; Hallmans G; Adlercreutz H
Cancer Causes Control; 2004 Dec; 15(10):1095-102. PubMed ID: 15801493
[TBL] [Abstract][Full Text] [Related]
3. Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study.
Stattin P; Adlercreutz H; Tenkanen L; Jellum E; Lumme S; Hallmans G; Harvei S; Teppo L; Stumpf K; Luostarinen T; Lehtinen M; Dillner J; Hakama M
Int J Cancer; 2002 May; 99(1):124-9. PubMed ID: 11948503
[TBL] [Abstract][Full Text] [Related]
4. Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study (Sweden).
Hedelin M; Klint A; Chang ET; Bellocco R; Johansson JE; Andersson SO; Heinonen SM; Adlercreutz H; Adami HO; Grönberg H; Bälter KA
Cancer Causes Control; 2006 Mar; 17(2):169-80. PubMed ID: 16425095
[TBL] [Abstract][Full Text] [Related]
5. Intake of whole grains and vegetables determines the plasma enterolactone concentration of Danish women.
Johnsen NF; Hausner H; Olsen A; Tetens I; Christensen J; Knudsen KE; Overvad K; Tjønneland A
J Nutr; 2004 Oct; 134(10):2691-7. PubMed ID: 15465768
[TBL] [Abstract][Full Text] [Related]
6. Serum enterolactone concentration is not associated with prostate cancer risk in a nested case-control study.
Kilkkinen A; Virtamo J; Virtanen MJ; Adlercreutz H; Albanes D; Pietinen P
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1209-12. PubMed ID: 14652283
[TBL] [Abstract][Full Text] [Related]
7. Enterolactone is differently associated with estrogen receptor beta-negative and -positive breast cancer in a Swedish nested case-control study.
Sonestedt E; Borgquist S; Ericson U; Gullberg B; Olsson H; Adlercreutz H; Landberg G; Wirfält E
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3241-51. PubMed ID: 18990767
[TBL] [Abstract][Full Text] [Related]
8. Risk of acute coronary events according to serum concentrations of enterolactone: a prospective population-based case-control study.
Vanharanta M; Voutilainen S; Lakka TA; van der Lee M; Adlercreutz H; Salonen JT
Lancet; 1999 Dec 18-25; 354(9196):2112-5. PubMed ID: 10609816
[TBL] [Abstract][Full Text] [Related]
9. Plasma enterolactone and breast cancer incidence by estrogen receptor status.
Olsen A; Knudsen KE; Thomsen BL; Loft S; Stripp C; Overvad K; Møller S; Tjønneland A
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2084-9. PubMed ID: 15598765
[TBL] [Abstract][Full Text] [Related]
10. Factors Explaining Interpersonal Variation in Plasma Enterolactone Concentrations in Humans.
Hålldin E; Eriksen AK; Brunius C; da Silva AB; Bronze M; Hanhineva K; Aura AM; Landberg R
Mol Nutr Food Res; 2019 Aug; 63(16):e1801159. PubMed ID: 30817848
[TBL] [Abstract][Full Text] [Related]
11. Consumption of wholemeal rye bread increases serum concentrations and urinary excretion of enterolactone compared with consumption of white wheat bread in healthy Finnish men and women.
Juntunen KS; Mazur WM; Liukkonen KH; Uehara M; Poutanen KS; Adlercreutz HC; Mykkänen HM
Br J Nutr; 2000 Dec; 84(6):839-46. PubMed ID: 11177200
[TBL] [Abstract][Full Text] [Related]
12. Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland.
Pietinen P; Stumpf K; Männistö S; Kataja V; Uusitupa M; Adlercreutz H
Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):339-44. PubMed ID: 11319174
[TBL] [Abstract][Full Text] [Related]
13. Relation between plasma enterodiol and enterolactone and dietary intake of lignans in a Dutch endoscopy-based population.
Milder IE; Kuijsten A; Arts IC; Feskens EJ; Kampman E; Hollman PC; Van 't Veer P
J Nutr; 2007 May; 137(5):1266-71. PubMed ID: 17449591
[TBL] [Abstract][Full Text] [Related]
14. Circulating enterolactone concentrations and prognosis of postmenopausal breast cancer: assessment of mediation by inflammatory markers.
Jaskulski S; Jung AY; Behrens S; Johnson T; Kaaks R; Thöne K; Flesch-Janys D; Sookthai D; Chang-Claude J
Int J Cancer; 2018 Dec; 143(11):2698-2708. PubMed ID: 29974464
[TBL] [Abstract][Full Text] [Related]
15. Serum enterolactone concentration is not associated with breast cancer risk in a nested case-control study.
Kilkkinen A; Virtamo J; Vartiainen E; Sankila R; Virtanen MJ; Adlercreutz H; Pietinen P
Int J Cancer; 2004 Jan; 108(2):277-80. PubMed ID: 14639615
[TBL] [Abstract][Full Text] [Related]
16. Impact of a lignan-rich diet on adiposity and insulin sensitivity in post-menopausal women.
Morisset AS; Lemieux S; Veilleux A; Bergeron J; John Weisnagel S; Tchernof A
Br J Nutr; 2009 Jul; 102(2):195-200. PubMed ID: 19586570
[TBL] [Abstract][Full Text] [Related]
17. Phyto-oestrogens and risk of prostate cancer in Scottish men.
Heald CL; Ritchie MR; Bolton-Smith C; Morton MS; Alexander FE
Br J Nutr; 2007 Aug; 98(2):388-96. PubMed ID: 17403269
[TBL] [Abstract][Full Text] [Related]
18. Dietary determinants of plasma enterolactone.
Horner NK; Kristal AR; Prunty J; Skor HE; Potter JD; Lampe JW
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):121-6. PubMed ID: 11815409
[TBL] [Abstract][Full Text] [Related]
19. Prediagnostic enterolactone concentrations and mortality among Danish men diagnosed with prostate cancer.
Eriksen AK; Kyrø C; Nørskov N; Bolvig AK; Christensen J; Tjønneland A; Overvad K; Landberg R; Olsen A
Eur J Clin Nutr; 2017 Oct; 71(10):1235-1240. PubMed ID: 28378849
[TBL] [Abstract][Full Text] [Related]
20. Plasma enterolactone and risk of colon and rectal cancer in a case-cohort study of Danish men and women.
Johnsen NF; Olsen A; Thomsen BL; Christensen J; Egeberg R; Bach Knudsen KE; Loft S; Overvad K; Tjønneland A
Cancer Causes Control; 2010 Jan; 21(1):153-62. PubMed ID: 19844797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
